CariGenetics Marks Third Anniversary
CariGenetics — founded in 2022 by Dr Carika Weldon – is celebrating its third anniversary, with Dr Weldon saying “we are showing the world that Caribbean science matters.”
A spokesperson said, “CariGenetics, the sole genomic research company dedicated exclusively to people of Caribbean ancestry, proudly celebrates its third anniversary of incorporation today. Founded in 2022 by Dr Carika Weldon, CariGenetics has rapidly grown into a globally recognised leader in precision medicine, health equity, and community-driven science.
“In just three years, CariGenetics has made genetic testing accessible to over 1,300 Caribbean people, discovered unique trends in cancer genetics, pharmacogenetics, and cannabis metabolism and has launched the Caribbean Genome Programme, set to genetically test 250,000 Caribbean people by 2030.”
“Three years ago, I took a leap of faith and founded CariGenetics, having never run a company before. Although I did not know exactly what challenges lay ahead, I knew the vision that needed to be executed: Caribbean people deserve to be included in the science shaping the future of healthcare,” said Dr Weldon.
“They say the three-year mark is the ‘make or break’ point for most companies. Nearly 90% don’t make it past this stage. To be standing here today has not been easy. We have made many mistakes, learned many lessons but have powered through as our mission is great. CariGenetics is here to stay – to make history from the Caribbean for the world.
“We would not be here without our dedicated team, our partners, our investors, and most importantly the communities in Bermuda and across the Caribbean. Together, we are showing the world that Caribbean science matters.”
